MedTrace Logo

Mitral Valve Regurgitation Quantification From 3D Color Doppler Ultrasound - Standard of Care Data Collection

NCT03286088 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2021-10-27

No results posted yet for this study

Summary

The study primarily aims to collect standard of care clinical data in a wide spectrum of simple to complex mitral valve regurgitation (MVR) cases to validate a post-processing stand-alone software prototype (QFlow), developed by Philips Research Paris (Medisys).

Investigator does not intervene in the care of the patient, but simply collects standard of care images and measurements that are needed for the validation of the investigational software.

Conditions

  • Mitral Valve Regurgitation of Any Grade

Interventions

DIAGNOSTIC_TEST

TransEsophageal Echocardiography and TransEsophageal Echocardiography

imaging as standard practice

DIAGNOSTIC_TEST

Cardiac Magnetics Resonance

imaging as standard practice

DIAGNOSTIC_TEST

MitraClip

imaging as standard practice

Sponsors & Collaborators

  • Philips Electronics Nederland B.V. acting through Philips CTO organization

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-22
Primary Completion
2019-07-31
Completion
2019-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03286088 on ClinicalTrials.gov